- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RSNA 2020: Addressing Healthcare Disparities and Access to Care
Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Work has been ongoing for years to decrease the presence and impact of disparities throughout healthcare, including in radiology. But, problems still exist, and there are new challenges on the horizon that could make it more difficult for radiologists to make it easier for patients to get the imaging services they need.
During this year's Radiological Society of North America (RSNA) annual meeting, Richard Heller, M.D., associate chief medical officer and national director of pediatric radiology with Radiology Partners, and Lucy Spalluto, M.D., associate professor of radiology and radiological sciences at Vanderbilt University School of Medicine, participated in a session dedicated to addressing the continued existence of health disparities.
In this episode of The Reading Room, they talk with Diagnostic Imaging about the underlying factors that result in healthcare disparities, as well as the challenges providers and facilities face to improving access to care.
For additional RSNA coverage, click here.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
